Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

CNTBCNTB
4 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in CONNECT BIOPHARMA HLDGS LTD

Yes. Susquehanna International Group holds 102,148 shares of CNTB (Connect Biopharma), worth $243,112, as of its Q2 2026 13F filing. It reduced the position by 176,660 shares (-63.4%) from Q1 2026. Susquehanna International Group has held CNTB since Q3 2025, across 4 quarterly 13F filings.

Current Value

$243,112

Current Shares

102,148

Total Value Change

+$222,765

Total Shares Change

+88,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
102,148
-63.4%
$243,1120.0%$2.38
0
2026-Q1
Increased
278,808
+289.9%
$730,4770.0%$2.48
40
2025-Q4
Increased
71,503
+420.1%
$201,6380.0%$2.70
25
2025-Q3
New
13,748
-
$20,3470.0%$1.32
29

Other major holders of CNTB: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used